The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brown, T. J.
Right arrow Articles by Shoyab, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brown, T. J.
Right arrow Articles by Shoyab, M.

The Journal of Immunology, Vol 147, Issue 7 2175-2180, Copyright © 1991 by American Association of Immunologists

ARTICLES

Regulation of IL-6 expression by oncostatin M

TJ Brown, JM Rowe, JW Liu and M Shoyab
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, WA 98121.

Endothelial cells produce immunomodulatory cytokines in response to soluble mediators of inflammatory/immune reactions. We have previously demonstrated that the leukocyte-derived cytokine, oncostatin M (Onco M) can alter endothelial cell morphology, regeneration, and fibrinolytic activity in vitro. Here we demonstrate that Onco M stimulates the production of the pleiotropic cytokine, IL-6, in cultured human endothelial cells (HEC) in a time- and dose-dependent manner. Specific antibodies to IL-6 neutralize the growth-inhibitory activity for human breast carcinoma cells that is secreted by HEC in response to Onco M treatment. Specific immunoassays indicate greater than 10-fold increases in the IL-6 content of culture supernatants as early as 6 h post-treatment with Onco M (ED50 = 17 pM). This stimulation of IL-6 production by Onco M is associated with a sevenfold increase in intracellular levels of IL-6 mRNA. IL-1 alpha and TNF-alpha are also potent inducers of IL-6 production in these cells, the order of potency being IL-1 alpha greater than Onco M greater than TNF-alpha. TNF-alpha, but not IL-1 alpha, synergizes with Onco M to augment IL-6 production in HEC. HEC are 10 to 20 times more responsive to Onco M than are other nonendothelial cell types. In addition, HEC express 10 to 20 times greater numbers of high affinity cell-surface receptors for Onco M than do other nonendothelial cell types. Based on these findings, we propose that Onco M may represent a new immunomodulator regulating cytokine- induced gene products in endothelial cells.


This article has been cited by other articles:


Home page
 Am. J. Pathol.Home page
T. Hamada, A. Sato, T. Hirano, T. Yamamoto, G. Son, M. Onodera, I. Torii, T. Nishigami, M. Tanaka, A. Miyajima, et al.
Oncostatin M Gene Therapy Attenuates Liver Damage Induced by Dimethylnitrosamine in Rats
Am. J. Pathol., September 1, 2007; 171(3): 872 - 881.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. C. Smyth, C. Kerr, and C. D. Richards
Oncostatin M-Induced IL-6 Expression in Murine Fibroblasts Requires the Activation of Protein Kinase C{delta}
J. Immunol., December 15, 2006; 177(12): 8740 - 8747.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
L. Yao, T. Yokota, L. Xia, P. W. Kincade, and R. P. McEver
Bone marrow dysfunction in mice lacking the cytokine receptor gp130 in endothelial cells
Blood, December 15, 2005; 106(13): 4093 - 4101.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. S. Faffe, L. Flynt, M. Mellema, T. R. Whitehead, K. Bourgeois, R. A. Panettieri Jr., E. S. Silverman, and S. A. Shore
Oncostatin M causes VEGF release from human airway smooth muscle: synergy with IL-1{beta}
Am J Physiol Lung Cell Mol Physiol, June 1, 2005; 288(6): L1040 - L1048.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
H. Yuan, F. J. Liddle, S. Mahajan, and D. A. Frank
IL-6-induced survival of colorectal carcinoma cells is inhibited by butyrate through down-regulation of the IL-6 receptor
Carcinogenesis, November 1, 2004; 25(11): 2247 - 2255.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
T. Nagata, H. Kai, R. Shibata, M. Koga, A. Yoshimura, and T. Imaizumi
Oncostatin M, an Interleukin-6 Family Cytokine, Upregulates Matrix Metalloproteinase-9 Through the Mitogen-Activated Protein Kinase Kinase-Extracellular Signal-Regulated Kinase Pathway in Cultured Smooth Muscle Cells
Arterioscler. Thromb. Vasc. Biol., April 1, 2003; 23(4): 588 - 593.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. M. Hurst, R. M. McLoughlin, J. Monslow, S. Owens, L. Morgan, G. M. Fuller, N. Topley, and S. A. Jones
Secretion of Oncostatin M by Infiltrating Neutrophils: Regulation of IL-6 and Chemokine Expression in Human Mesothelial Cells
J. Immunol., November 1, 2002; 169(9): 5244 - 5251.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
F Ensoli, V Fiorelli, A Lugaresi, D Farina, M DeCristofaro, B Collacchi, D S. Muratori, E Scala, M Di Gioacchino, R Paganelli, et al.
Lymphomononuclear cells from multiple sclerosis patients spontaneously produce high levels of oncostatin M, tumor necrosis factors {alpha} and {beta}, and interferon {gamma}
Multiple Sclerosis, August 1, 2002; 8(4): 284 - 288.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
K. Mahboubi and J. S. Pober
Activation of Signal Transducer and Activator of Transcription 1 (STAT1) Is Not Sufficient for the Induction of STAT1-dependent Genes in Endothelial Cells. COMPARISON OF INTERFERON-gamma AND ONCOSTATIN M
J. Biol. Chem., March 1, 2002; 277(10): 8012 - 8021.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. Somasundaram, M. Ruehl, B. Schaefer, M. Schmid, R. Ackermann, E. O. Riecken, M. Zeitz, and D. Schuppan
Interstitial Collagens I, III, and VI Sequester and Modulate the Multifunctional Cytokine Oncostatin M
J. Biol. Chem., January 25, 2002; 277(5): 3242 - 3246.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
A F Wahl and P M Wallace
Oncostatin M in the anti-inflammatory response
Ann Rheum Dis, November 1, 2001; 60(90003): iii75 - 80.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. Nishibe, G. Parry, A. Ishida, S. Aziz, J. Murray, Y. Patel, S. Rahman, K. Strand, K. Saito, Y. Saito, et al.
Oncostatin M promotes biphasic tissue factor expression in smooth muscle cells: evidence for Erk-1/2 activation
Blood, February 1, 2001; 97(3): 692 - 699.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
C. Langdon, C. Kerr, M. Hassen, T. Hara, A. L. Arsenault, and C. D. Richards
Murine Oncostatin M Stimulates Mouse Synovial Fibroblasts in Vitro and Induces Inflammation and Destruction in Mouse Joints in Vivo
Am. J. Pathol., October 1, 2000; 157(4): 1187 - 1196.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
M. M. Inserra, M. Yao, R. Murray, and D. J. Terris
Peripheral Nerve Regeneration in Interleukin 6-Deficient Mice
Arch Otolaryngol Head Neck Surg, September 1, 2000; 126(9): 1112 - 1116.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Ihn and K. Tamaki
Oncostatin M Stimulates the Growth of Dermal Fibroblasts Via a Mitogen-Activated Protein Kinase-Dependent Pathway
J. Immunol., August 15, 2000; 165(4): 2149 - 2155.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Mahboubi, B. C. Biedermann, J. M. Carroll, and J. S. Pober
IL-11 Activates Human Endothelial Cells to Resist Immune-Mediated Injury
J. Immunol., April 1, 2000; 164(7): 3837 - 3846.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
C. Bernard, R. Merval, M. Lebret, P. Delerive, I. Dusanter-Fourt, S. Lehoux, C. Creminon, B. Staels, J. Maclouf, and A. Tedgui
Oncostatin M Induces Interleukin-6 and Cyclooxygenase-2 Expression in Human Vascular Smooth Muscle Cells : Synergy With Interleukin-1{beta}
Circ. Res., December 3, 1999; 85(12): 1124 - 1131.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
L. Yao, H. Setiadi, L. Xia, Z. Laszik, F. B. Taylor, and R. P. McEver
Divergent Inducible Expression of P-Selectin and E-Selectin in Mice and Primates
Blood, December 1, 1999; 94(11): 3820 - 3828.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. Vasse, J. Pourtau, V. Trochon, M. Muraine, J.-P. Vannier, H. Lu, J. Soria, and C. Soria
Oncostatin M Induces Angiogenesis In Vitro and In Vivo
Arterioscler. Thromb. Vasc. Biol., August 1, 1999; 19(8): 1835 - 1842.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
P. G. Murphy, L. S. Borthwick, R. S. Johnston, G. Kuchel, and P. M. Richardson
Nature of the Retrograde Signal from Injured Nerves that Induces Interleukin-6 mRNA in Neurons
J. Neurosci., May 15, 1999; 19(10): 3791 - 3800.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. M. Wallace, J. F. MacMaster, K. A. Rouleau, T. J. Brown, J. K. Loy, K. L. Donaldson, and A. F. Wahl
Regulation of Inflammatory Responses by Oncostatin M
J. Immunol., May 1, 1999; 162(9): 5547 - 5555.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
J. K. Loy, T. J. Davidson, K. K. Berry, J. F. Macmaster, B. Danle, and S. K. Durham
Oncostatin M: Development of a Pleiotropic Cytokine
Toxicol Pathol, March 1, 1999; 27(2): 151 - 155.
[Abstract] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
O. Saijonmaa, T. Nyman, P. Pacek, and F. Fyhrquist
Oncostatin M regulates endothelin-1 production in human endothelial cells
Am J Physiol Heart Circ Physiol, August 1, 1998; 275(2): H662 - H667.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. Korzus, H. Nagase, R. Rydell, and J. Travis
The Mitogen-activated Protein Kinase and JAK-STAT Signaling Pathways Are Required for an Oncostatin M-responsive Element-mediated Activation of Matrix Metalloproteinase 1Gene Expression
J. Biol. Chem., January 10, 1997; 272(2): 1188 - 1196.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
E. Wijelath, B Carlsen, T Cole, J Chen, S Kothari, and W. Hammond
Oncostatin M induces basic fibroblast growth factor expression in endothelial cells and promotes endothelial cell proliferation, migration and spindle morphology
J. Cell Sci., January 4, 1997; 110(7): 871 - 879.
[Abstract] [PDF]

Home page
 ScienceHome page
S. Miles, O Martinez-Maza, A Rezai, L Magpantay, T Kishimoto, S Nakamura, S. Radka, and P. Linsley
Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells
Science, March 13, 1992; 255(5050): 1432 - 1434.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
A. Rhodes, A. Deakin, J. Spaull, B. Coomber, A. Aitken, P. Life, and S. Rees
The Generation and Characterization of Antagonist RNA Aptamers to Human Oncostatin M
J. Biol. Chem., September 8, 2000; 275(37): 28555 - 28561.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.